AUNA S.A. - AUNA STOCK NEWS

Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024. The report was filed with the Securities and Exchange Commission (SEC) on April 10, 2025.

The Annual Report can be accessed through the SEC's website or the 'Financial Info' section of Auna's Investor Relations website. Shareholders can also request a free hard copy of the company's audited financial statements or complete 2024 Form 20-F by contacting the Investor Relations team.

Auna (NYSE: AUNA), a Latin American healthcare platform, reported strong financial results for Q4 and FY 2024. Fourth quarter highlights include:

• Revenue up 4% YoY to S/1,063 million (+11% FXN)
• Adjusted EBITDA increased 19% YoY to S/254 million (+28% FXN)
• Adjusted EBITDA margin expanded 3.1 p.p. to 23.9%
• Net Income improved to S/24 million from a loss of S/219 million in 4Q23

Full-year 2024 performance showed:

• Revenue growth of 13% YoY to S/4,386 million
• Adjusted EBITDA rose 20% YoY to S/993 million
• Net Income of S/124 million, compared to a loss of S/214 million in 2023
• Leverage ratio improved to 3.6x from 4.5x in 4Q23

The company faced challenges in Colombia with certain payors but showed strong momentum in Mexico and Peru. Auna maintains its internal guideline of 20% FXN Adjusted EBITDA growth annually, though 2025 performance will depend on Colombian operations.

Auna S.A. (NYSE: AUNA) has signed an exclusive five-year agreement with Opción Oncología, Monterrey's premier oncology ambulatory clinic. The partnership brings eight distinguished physicians (six oncologists and two radiation oncologists) to Auna's network, who currently manage approximately 30% of private oncology treatments in Monterrey.

The medical team will relocate to Doctors Hospital, integrating 100% of their treatments within Auna's network over time. Notable additions include Dr. César González de León, appointed as Chair of Medical Oncology, and Dr. Cuauhtémoc De la Peña Hinojosa, who will serve as Chair of Radiation Oncology on Auna Mexico's Oncology Board.

This strategic move follows the launch of OncoMexico and precedes the inauguration of Auna's Oncology Research Center in Mexico, which will collaborate with existing research centers in Peru and Colombia.

Auna (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its Fourth Quarter and Full-Year 2024 financial results announcement. The earnings release will be published on Monday, March 10, 2025, after market close. A conference call will follow on Tuesday, March 11, 2025, at 8:00 a.m. ET. The company has established a quiet period from February 17 through March 10, 2025. Interested parties can participate via phone using the toll-free number +1 888 596 4144 or international number +1 646 968 2525 with entry passcode 3884034, or join through the webcast.

Auna S.A. (NYSE: AUNA), a Latin American healthcare company operating in Mexico, Peru and Colombia, has announced the completion of a private placement of USD 57.8 million in 10.000% Senior Secured Notes due 2029. The proceeds were used to fully redeem its existing 6.500% Senior Secured Notes due 2025, at a redemption price of 101.625% plus interest. These Additional 2029 Notes were issued under the same indenture as the company's outstanding USD 253 million 10.000% Senior Secured Notes from December 2023, bringing the total outstanding amount to USD 310.8 million.

Auna (NYSE: AUNA), a leading Latin American healthcare company, has appointed two new independent directors to its Board effective January 1, 2025. Teresa Gutierrez, currently responsible for Tesla in Mexico, and Guadalupe Phillips, CEO of ICA, will join the board, bringing the total member count to nine, including five independent directors.

Gutierrez brings 20 years of experience in e-commerce, logistics, and marketing, while Phillips contributes expertise in organic and inorganic growth along with financial acumen. Both appointees hold multiple board positions across various companies and bring diverse expertise to support Auna's expansion plans in Mexico and Latin America.

Auna (NYSE: AUNA) reported strong Q3 2024 financial results with consolidated revenue increasing 11% YoY to S/1,127 million. Adjusted EBITDA grew 18% YoY to S/250 million, with margin expanding 1.4 p.p. to 22.1%. The company improved its leverage ratio to 3.7x from 4.1x in Q2 2024. Net Income reached S/101 million, compared to a Net Loss of S/18 million in Q3 2023. Notable operational improvements include increased consolidated capacity utilization to 67% and improved Oncology Plan MLR at 53.7%. The company showed strong performance across its markets, with revenue growth of 16% in Mexico, 13% in Peru, and 11% in Colombia in local currency terms.

Auna (NYSE: AUNA), a Latin American healthcare services and plan provider operating in Mexico, Peru and Colombia, has scheduled its Third Quarter 2024 financial results announcement. The earnings release will be published after market close on Tuesday, November 19, 2024, followed by a conference call on Wednesday, November 20, 2024 at 8:00 a.m. ET. The company will observe a quiet period from November 11 through November 19, 2024.

Auna S.A. (NYSE: AUNA), a Latin American healthcare company, has appointed Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets. With over 25 years of experience in consulting and investment banking, Massart brings valuable expertise to this newly created role. He has been a key advisor to Auna for the past three years, contributing to their expansion into Mexico and their transition to becoming a public company.

In his new position, Massart will oversee the Investor Relations function, ensuring a cohesive approach to communicating with investors and stakeholders. This appointment signals Auna's commitment to positioning senior talent in key roles and strengthening relationships with current and future investors.